Clin2
NCT06506175Possibly a fitNot yet recruiting

How the body processes a new tablet under different conditions

Weight ManagementType 2 Diabetes

Treatments studied

Part of Hormones & metabolism clinical trials.

This study tests how a new tablet (called HRS9531) is absorbed and processed by the body under different conditions (like with or without food). It is for healthy volunteers to find the best way to take the tablet.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
100 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are a male aged 18 to 55.
  • You weigh at least 50 kg and your body mass index (BMI) is between 23 and 35.
  • Your weight has not changed by more than 5 kg in the last 3 months.
  • You are in good general health, with no major organ diseases or significant infections.
  • You haven't donated blood recently and have no substance abuse or heavy smoking/drinking habits.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07841860Not yet recruiting· Phase 1
Weight loss study for healthy and obese adults

This study tests a new weight-loss medicine called HRS-1596. It is given as a tablet to see if it is safe and how well it works. The study first gives a single dose to healthy adults, then multiple doses to people with obesity.

Jinan, Shandong
NCT07193459Recruiting· Phase 3
Study of an oral tablet for type 2 diabetes

This trial tests an experimental daily tablet for adults with type 2 diabetes who are not currently on any diabetes medication. It aims to see if the tablet can safely lower blood sugar levels over time.

Beijing, Beijing Municipality
NCT07082114Recruiting· Phase 3
Testing a new tablet for type 2 diabetes

This study tests a new pill called HDM1002 for adults with type 2 diabetes. It aims to see if it helps control blood sugar when added to your current metformin treatment.

Yueyang, Hunan
NCT07060456Recruiting· Phase 3
New drug for type 2 diabetes with insulin

This trial tests a new medicine called HRS9531 for people with type 2 diabetes who already use basal insulin. It aims to see if adding this drug helps control blood sugar better.

Beijing, Beijing Municipality
NCT07150962Recruiting· Phase 1
Testing a new version of an obesity treatment pill

This trial compares two versions of the study drug HRS9531 in people with overweight or obesity to see which one works better in the body. It may help find a more effective treatment for weight management.

Hefei, Anhui
NCT07670884Recruiting· Phase 3
Study of HRS9531 for weight loss in overweight or obese adults

This trial tests an oral medication, HRS9531, to help overweight or obese adults lose weight. It may be an option if you have been unable to lose enough weight through diet and exercise alone.

Zhengzhou, Henan

Hear when a new Weight Management trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.